CpG ODN 7909 Adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CpG ODN 7909 Adjuvant, covering 2014-01-31 to 2014-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant [Phase 1]